VanEck Associates
ABMD

VanEck Associates’s Abiomed Inc ABMD Stock Holding History

VanEck Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,216
Closed -$1.53M – 1472
2022
Q3 		$1.53M Buy
6,216
+332
+6% +$89.7K ﹤0.01% 700
2022
Q2 		$1.46M Buy
5,884
+420
+8% +$113K ﹤0.01% 718
2022
Q1 		$1.81M Buy
5,464
+537
+11% +$165K ﹤0.01% 727
2021
Q4 		$1.77M Buy
4,927
+837
+20% +$283K ﹤0.01% 732
2021
Q3 		$1.33M Buy
4,090
+352
+9% +$119K ﹤0.01% 761
2021
Q2 		$1.17M Buy
+3,738
New +$1.15M ﹤0.01% 776
2020
Q2 		– Sell
-2,253
Closed -$327K – 1037
2020
Q1 		$327K Buy
2,253
+210
+10% +$34.9K ﹤0.01% 737
2019
Q4 		$349K Buy
+2,043
New +$379K ﹤0.01% 772

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

VanEck Associates's ABMD Position: Q4 2022 in Review

VanEck Associates sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,216 shares — an estimated $1.53M sold.

VanEck Associates first reported a position in ABMD in Q4 2019 and held it in 8 quarters. The position peaked at $1.81M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • VanEck Associates reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • VanEck Associates sold 6,216 Abiomed Inc shares in Q4 2022, an estimated $1.53M.
  • VanEck Associates first reported a position in Abiomed Inc in Q4 2019 and held it in 8 quarters.
  • VanEck Associates's Abiomed Inc position peaked at $1.81M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.